Back to Journals » Therapeutics and Clinical Risk Management » Volume 17

Ocrelizumab for the Treatment of Multiple Sclerosis: Safety, Efficacy, and Pharmacology

Total article views   HTML views PDF downloads Totals
11,005 Dovepress* 7,701+ 561 8,262
PubMed Central* 3,304 751 4,055
Totals 11,005 1,312 12,317
*Since 30 July 2021
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 2 2

View citations on PubMed Central and Google Scholar